B2B Medical GmbH, based in Rastatt, trades in pharmaceuticals, medical devices, cosmetics and other health products. With many years of experience the company has established itself as one of the market leaders in parallel imports for modern wound care products in original manufacturer quality and supplies pharmaceutical wholesalers, pharmacies and other healthcare partners. As a pharmaceutical wholesaler the company offers a broad product assortment of the common brand manufacturers in this segment. The average number of employees in the 2024 financial year remained unchanged at 111.
Der Handel mit Arzneimitteln, Medizinprodukten, kosmetischen Mitteln und sonstigen Gesund-heitsprodukten sowie alle Tätigkeiten, die dazu geeignet sind, den Unternehmensgegenstand direkt oder indirekt zu fördern.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 707387 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Frank Widmann | Geschäftsführer(in) | Nürnberg |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 707387 (as of 31 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 13.06.2019 | Business Address Change | Im Steingerüst 32, 76437 Rastatt |
| 06.09.2016 | Registered Seat Change | Rastatt |
| 06.09.2016 | Business Purpose Update | Der Handel mit Arzneimitteln, Medizinprodukten, kosmetischen Mitteln und sonstigen Gesund-heitsprodukten sowie alle Tätigkeiten, die dazu geeignet sind, den Unternehmensgegenstand direkt oder indirekt zu fördern. |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 17.08.2009 | Share Capital Set | — | 25.200 € |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 707387 (as of 31 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€14.5M2 | €2,244,831 | €8,508,174 | 111 |
| 2023 | Rohergebnis€13.2M2 | €2,258,866 | €7,725,738 | 111 |
| 2022 | Rohergebnis€11.5M2 | €1,062,815 | €8,119,423 | 111 |
| 2021 | Rohergebnis€10.6M2 | €1,593,421 | €8,197,284 | 99 |
| 2020 | Rohergebnis€8.7M2 | €1,996,876 | €7,487,565 | 86 |
| 2019 | Rohergebnis€8.6M2 | €2,933,846 | €6,502,060 | 64 |
| 2018 | Rohergebnis€5.9M2 | €2,698,732 | €7,660,190 | 42 |
| 2017 | small company1 | €1,850,173 | €3,857,617 | 30 |
| 2016 | small company1 | €593,135 | €1,824,428 | 18 |
| 2015 | small company1 | -€323,666 | €1,832,310 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 707387 (as of 31 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €6,150,456 | 93.1% |
| Depreciation | €445,891 | 6.8% |
| Interest & Similar | €8,927 | 0.1% |
